BUTLER NATIONAL – TEMPE EARNS NORTHROP GRUMMAN SILVER AWARD FOR QUARTERLY PERFORMANCE

Butler National Special Mission Electronics Team Recognized for Excellence in Performance and Quality Butler National – Tempe, a subsidiary of Butler National Corporation (OTCQX:BUKS) and a leading manufacturer of control systems, cabling, and test equipment for Special Mission Electronics, announced today that it has received the prestigious Northrop Grumman Corporation Silver Award. This award recognizes […]

Global Times: China’s longest river system reveals depth, richness of its non-stop civilization

Global Times: China's longest river system reveals depth, richness of its non-stop civilization Yangtze River shaped Chinese civilization, fostering culture, unity, ecology, and global exchanges through history. GlobeNewswire September 29, 2025 Beijing, China, Sept. 29, 2025 (GLOBE NEWSWIRE) — Rivers are the cradle of human civilization. From the cuneiform writing of Euphrates and Tigris to

Adapt or Scale: The Next Era of Law Firm Growth

Romano, Pond, Solomon Return for Part Two of High-Impact Law Firm Webinar Series Following the success of “Adapt or Die: Running Your Law Firm in the Modern Legal Landscape,” the Florida Justice Association is excited to announce the next installment in its exclusive webinar series: “Adapt or Scale: The Next Era of Law Firm Growth.”

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALT

NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALT

NEW YORK CITY, NY / ACCESS Newswire / September 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025

NEW YORK, NY / ACCESS Newswire / September 29, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=170003&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines – NVO

Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE:NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number

CheddrSuite Launches Direct Sysco EDI Integration, Bringing Real-Time Pricing and Cost Control to Restaurants

Direct Sysco EDI integration feeds live pricing into CheddrSuite, powering smarter plate costing, inventory, reporting, and financial control. CheddrSuite, the restaurant management platform built by operators, for operators, today announced a direct integration with Sysco's Electronic Data Interchange (EDI) system. By pulling live Sysco pricing directly into CheddrSuite, restaurants save hours of manual updates and

Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025

NEW YORK, NY / ACCESS Newswire / September 29, 2025 / If you suffered a loss on your Unicycive Therapeutics, Inc. (NASDAQ:UNCY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unicycive-therapeutics-inc-lawsuit-submission-form?prid=170003&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines – NVO

Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE:NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number

Scroll to Top